Mandate

VINGE ADVISES MVI EQUITY AB

July 01, 2014

Vinge has advised MVI Equity AB in connection with the joint acquisition together with Fouriertransform AB of SMP Parts, a leading designer and manufacturer of high quality machinery and accessories for excavators and loaders.

MVI Equity AB is an investment company which focuses on investments in medium-sized quality companies. MVI Equity AB consists of 100 entrepreneurs and managers who have invested in unlisted companies for more than 20 years. For more information, visit www.mvi.se.

Fouriertransform is a state-financed venture capital company which commercially supports innovative companies and entrepreneurs who can contribute to vitalizing the Swedish manufacturing industry.

Vinge’s team consisted of responsible partner Henrik Wenckert, partner Bo Adrianzon and, among others, associates Ulrich Ziche, Anna Lonergan and Malin Buch.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026